Nov 08, 2021 / NTS GMT
Presentation
Nov 08, 2021 / NTS GMT
=====================
Corporate Participants
=====================
* Akihisa Nabeshima
Teijin Limited - Executive Officer, CFO & Representative Director
* Junji Kitahama
Teijin Limited - Deputy CFO
=====================
Akihisa Nabeshima - Teijin Limited - Executive Officer, CFO & Representative Director
Thank you for joining us today. This is Akihisa Nabeshima, CFO. Please refer to the presentation entitled Flash Report Results of FY 2021 Second Quarter and Outlook for FY 2021.
Page 1, key points of this presentation. Owing to increased sales from the economic recovery and the effect of succession of the sales of diabetes treatment drugs from Takeda Pharmaceuticals, sales and profit increased year-on-year in the first half, despite the convergence of special demand for medical gowns, which contributed to profit in FY 2020. Net sales for the first 6 months amounted to JPY 453.4 billion. And operating income was JPY 31.5 billion. EBITDA was up 15% at JPY 65.1 billion.
No change
Q2 2022 Teijin Ltd Earnings Presentation Transcript
Nov 08, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers